Cargando…
Outbreak of Type 2 Vaccine-Derived Poliovirus in Nigeria: Emergence and Widespread Circulation in an Underimmunized Population
Wild poliovirus has remained endemic in northern Nigeria because of low coverage achieved in the routine immunization program and in supplementary immunization activities (SIAs). An outbreak of infection involving 315 cases of type 2 circulating vaccine-derived poliovirus (cVDPV2; >1% divergent f...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068031/ https://www.ncbi.nlm.nih.gov/pubmed/21402542 http://dx.doi.org/10.1093/infdis/jiq140 |
_version_ | 1782201173345828864 |
---|---|
author | Wassilak, Steven Pate, Muhammad Ali Wannemuehler, Kathleen Jenks, Julie Burns, Cara Chenoweth, Paul Abanida, Emmanuel Ade Adu, Festus Baba, Marycelin Gasasira, Alex Iber, Jane Mkanda, Pascal Williams, A. J. Shaw, Jing Pallansch, Mark Kew, Olen |
author_facet | Wassilak, Steven Pate, Muhammad Ali Wannemuehler, Kathleen Jenks, Julie Burns, Cara Chenoweth, Paul Abanida, Emmanuel Ade Adu, Festus Baba, Marycelin Gasasira, Alex Iber, Jane Mkanda, Pascal Williams, A. J. Shaw, Jing Pallansch, Mark Kew, Olen |
author_sort | Wassilak, Steven |
collection | PubMed |
description | Wild poliovirus has remained endemic in northern Nigeria because of low coverage achieved in the routine immunization program and in supplementary immunization activities (SIAs). An outbreak of infection involving 315 cases of type 2 circulating vaccine-derived poliovirus (cVDPV2; >1% divergent from Sabin 2) occurred during July 2005–June 2010, a period when 23 of 34 SIAs used monovalent or bivalent oral poliovirus vaccine (OPV) lacking Sabin 2. In addition, 21 “pre-VDPV2” (0.5%–1.0% divergent) cases occurred during this period. Both cVDPV and pre-VDPV cases were clinically indistinguishable from cases due to wild poliovirus. The monthly incidence of cases increased sharply in early 2009, as more children aged without trivalent OPV SIAs. Cumulative state incidence of pre-VDPV2/cVDPV2 was correlated with low childhood immunization against poliovirus type 2 assessed by various means. Strengthened routine immunization programs in countries with suboptimal coverage and balanced use of OPV formulations in SIAs are necessary to minimize risks of VDPV emergence and circulation. |
format | Text |
id | pubmed-3068031 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-30680312012-04-01 Outbreak of Type 2 Vaccine-Derived Poliovirus in Nigeria: Emergence and Widespread Circulation in an Underimmunized Population Wassilak, Steven Pate, Muhammad Ali Wannemuehler, Kathleen Jenks, Julie Burns, Cara Chenoweth, Paul Abanida, Emmanuel Ade Adu, Festus Baba, Marycelin Gasasira, Alex Iber, Jane Mkanda, Pascal Williams, A. J. Shaw, Jing Pallansch, Mark Kew, Olen J Infect Dis Major Articles and Brief Reports Wild poliovirus has remained endemic in northern Nigeria because of low coverage achieved in the routine immunization program and in supplementary immunization activities (SIAs). An outbreak of infection involving 315 cases of type 2 circulating vaccine-derived poliovirus (cVDPV2; >1% divergent from Sabin 2) occurred during July 2005–June 2010, a period when 23 of 34 SIAs used monovalent or bivalent oral poliovirus vaccine (OPV) lacking Sabin 2. In addition, 21 “pre-VDPV2” (0.5%–1.0% divergent) cases occurred during this period. Both cVDPV and pre-VDPV cases were clinically indistinguishable from cases due to wild poliovirus. The monthly incidence of cases increased sharply in early 2009, as more children aged without trivalent OPV SIAs. Cumulative state incidence of pre-VDPV2/cVDPV2 was correlated with low childhood immunization against poliovirus type 2 assessed by various means. Strengthened routine immunization programs in countries with suboptimal coverage and balanced use of OPV formulations in SIAs are necessary to minimize risks of VDPV emergence and circulation. Oxford University Press 2011-04-01 /pmc/articles/PMC3068031/ /pubmed/21402542 http://dx.doi.org/10.1093/infdis/jiq140 Text en Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2011. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/byc/2.5), which permits unrestricted nonommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Major Articles and Brief Reports Wassilak, Steven Pate, Muhammad Ali Wannemuehler, Kathleen Jenks, Julie Burns, Cara Chenoweth, Paul Abanida, Emmanuel Ade Adu, Festus Baba, Marycelin Gasasira, Alex Iber, Jane Mkanda, Pascal Williams, A. J. Shaw, Jing Pallansch, Mark Kew, Olen Outbreak of Type 2 Vaccine-Derived Poliovirus in Nigeria: Emergence and Widespread Circulation in an Underimmunized Population |
title | Outbreak of Type 2 Vaccine-Derived Poliovirus in Nigeria: Emergence and Widespread Circulation in an Underimmunized Population |
title_full | Outbreak of Type 2 Vaccine-Derived Poliovirus in Nigeria: Emergence and Widespread Circulation in an Underimmunized Population |
title_fullStr | Outbreak of Type 2 Vaccine-Derived Poliovirus in Nigeria: Emergence and Widespread Circulation in an Underimmunized Population |
title_full_unstemmed | Outbreak of Type 2 Vaccine-Derived Poliovirus in Nigeria: Emergence and Widespread Circulation in an Underimmunized Population |
title_short | Outbreak of Type 2 Vaccine-Derived Poliovirus in Nigeria: Emergence and Widespread Circulation in an Underimmunized Population |
title_sort | outbreak of type 2 vaccine-derived poliovirus in nigeria: emergence and widespread circulation in an underimmunized population |
topic | Major Articles and Brief Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068031/ https://www.ncbi.nlm.nih.gov/pubmed/21402542 http://dx.doi.org/10.1093/infdis/jiq140 |
work_keys_str_mv | AT wassilaksteven outbreakoftype2vaccinederivedpoliovirusinnigeriaemergenceandwidespreadcirculationinanunderimmunizedpopulation AT patemuhammadali outbreakoftype2vaccinederivedpoliovirusinnigeriaemergenceandwidespreadcirculationinanunderimmunizedpopulation AT wannemuehlerkathleen outbreakoftype2vaccinederivedpoliovirusinnigeriaemergenceandwidespreadcirculationinanunderimmunizedpopulation AT jenksjulie outbreakoftype2vaccinederivedpoliovirusinnigeriaemergenceandwidespreadcirculationinanunderimmunizedpopulation AT burnscara outbreakoftype2vaccinederivedpoliovirusinnigeriaemergenceandwidespreadcirculationinanunderimmunizedpopulation AT chenowethpaul outbreakoftype2vaccinederivedpoliovirusinnigeriaemergenceandwidespreadcirculationinanunderimmunizedpopulation AT abanidaemmanuelade outbreakoftype2vaccinederivedpoliovirusinnigeriaemergenceandwidespreadcirculationinanunderimmunizedpopulation AT adufestus outbreakoftype2vaccinederivedpoliovirusinnigeriaemergenceandwidespreadcirculationinanunderimmunizedpopulation AT babamarycelin outbreakoftype2vaccinederivedpoliovirusinnigeriaemergenceandwidespreadcirculationinanunderimmunizedpopulation AT gasasiraalex outbreakoftype2vaccinederivedpoliovirusinnigeriaemergenceandwidespreadcirculationinanunderimmunizedpopulation AT iberjane outbreakoftype2vaccinederivedpoliovirusinnigeriaemergenceandwidespreadcirculationinanunderimmunizedpopulation AT mkandapascal outbreakoftype2vaccinederivedpoliovirusinnigeriaemergenceandwidespreadcirculationinanunderimmunizedpopulation AT williamsaj outbreakoftype2vaccinederivedpoliovirusinnigeriaemergenceandwidespreadcirculationinanunderimmunizedpopulation AT shawjing outbreakoftype2vaccinederivedpoliovirusinnigeriaemergenceandwidespreadcirculationinanunderimmunizedpopulation AT pallanschmark outbreakoftype2vaccinederivedpoliovirusinnigeriaemergenceandwidespreadcirculationinanunderimmunizedpopulation AT kewolen outbreakoftype2vaccinederivedpoliovirusinnigeriaemergenceandwidespreadcirculationinanunderimmunizedpopulation |